This segment encompasses the core business of Voxel S.A., providing a comprehensive range of diagnostic imaging services. These include Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), and Single Photon Emission Computed Tomography (SPECT) scans. Research and development activities focus on optimizing imaging protocols, improving image quality, and reducing radiation exposure. The segment utilizes advanced technologies such as high-field MRI scanners, multi-slice CT scanners, and PET/CT and SPECT/CT systems. Therapeutic areas covered include oncology, neurology, cardiology, and other specialties. The patient impact is significant, as accurate and timely diagnoses are crucial for effective treatment. Voxel S.A. holds a strong market position as a leading private provider of diagnostic services in Poland. Future opportunities include expanding service offerings, integrating AI-powered image analysis tools, and exploring new imaging modalities. Regulatory compliance is ensured through adherence to national and international standards, and partnerships with medical device manufacturers and healthcare providers are key to success.

This segment focuses on providing teleradiology services and outsourcing solutions to hospitals and diagnostic centers. Teleradiology involves the remote interpretation of medical images by radiologists, enabling faster and more efficient diagnoses. Outsourcing services include providing IT solutions for hospitals and diagnostic centers. Research and development efforts are directed towards developing secure and efficient image transfer and storage systems, as well as improving the accuracy and speed of image interpretation. The segment utilizes advanced IT infrastructure, including secure networks, image archiving systems (PACS), and reporting platforms. Therapeutic areas covered are broad, encompassing all medical specialties that utilize imaging. The patient impact is improved access to expert radiology interpretations and reduced turnaround times for diagnoses. Voxel S.A. leverages its network of radiologists and advanced technology to offer competitive teleradiology and outsourcing services. Future opportunities include expanding the range of services offered, integrating AI-powered diagnostic tools, and expanding into new geographic markets. Regulatory compliance is crucial, particularly regarding data privacy and security, and partnerships with healthcare providers and technology vendors are essential.

This segment involves the production and supply of radiopharmaceuticals used in PET imaging. Research and development activities focus on the development and optimization of radiopharmaceutical production processes, including the use of cyclotrons and other advanced technologies. The segment utilizes advanced technologies such as cyclotrons for isotope production and specialized radiopharmaceutical synthesis modules. Therapeutic areas covered include oncology, cardiology, and neurology, where radiopharmaceuticals are used for diagnosis and treatment monitoring. The patient impact is significant, as radiopharmaceuticals enable the detection and characterization of diseases at the molecular level. Voxel S.A. is involved in the production of radiopharmaceuticals, ensuring the availability of essential diagnostic tools. Future opportunities include expanding the range of radiopharmaceuticals produced, developing new diagnostic agents, and exploring theranostic applications. Regulatory compliance is critical, with adherence to stringent quality control standards and pharmaceutical regulations. Partnerships with research institutions and pharmaceutical companies are important for innovation and market access.